Skip to content

APHARGA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APHARGA

BE 0762.565.401
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€3,449
2024 · €6,324-€2,876
Equity
€16,478
2024 · €44,030-€27,551
Cash
€20,457
2024 · €46,163-€25,706
Balance sheet total
€23,536
2024 · €51,378-€27,842

Largest movements

2024 to 2025
Assets
  • Cash -€25,706

    down €25,706 (-55.7%), from €46,163 to €20,457

    mainly Contributions, distributions and other (-€31,000) and Tax, wage and social debts (-€419)

  • Deferred charges and accrued income -€1,826

    down €1,826 (-50.0%), from €3,653 to €1,826

Equity and liabilities
  • Profit (loss) carried forward -€27,551

    down €27,551 (-65.6%), from €42,030 to €14,478

Income statement
  • Gross operating margin -€4,152

    down €4,152 (-38.1%), from €10,900 to €6,748

  • Depreciation -€595

    no longer reported in 2025 (was €595)

  • Taxes -€429

    down €429 (-20.2%), from €2,119 to €1,690

  • Financial charges -€253

    down €253 (-15.3%), from €1,658 to €1,405

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €6,324
Gross operating margin -€4,152
Depreciation +€595
Other operating charges -€1
Financial charges +€253
Taxes +€429
Result 2025 €3,449

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€5,294
Investment €0
Financing -€31,000
Cash 2024 €46,163
Net result for the year +€3,449
Receivables within one year +€309
Deferred charges and accrued income +€1,826
Trade debts +€143
Tax, wage and social debts -€419
Other debts -€14
Contributions, distributions and other -€31,000
Cash 2025 €20,457
Every line side by side 27 lines
Line Code 2024 2025 Change %
Total assets 20/58 €51,378 €23,536 -€27,842 -54.2%
Current assets 29/58 €51,378 €23,536 -€27,842 -54.2%
Amounts receivable within one year 40/41 €1,562 €1,253 -€309 -19.8%
Trade receivables 40 €1,562 €1,253 -€309 -19.8%
Cash at bank and in hand 54/58 €46,163 €20,457 -€25,706 -55.7%
Deferred charges and accrued income 490/1 €3,653 €1,826 -€1,826 -50.0%
Total equity and liabilities 10/49 €51,378 €23,536 -€27,842 -54.2%
Equity 10/15 €44,030 €16,478 -€27,551 -62.6%
Contributions 10/11 €2,000 €2,000 = 0.0%
Profit (loss) carried forward 14 €42,030 €14,478 -€27,551 -65.6%
Amounts payable 17/49 €7,348 €7,058 -€290 -4.0%
Amounts payable within one year 42/48 €7,348 €7,058 -€290 -4.0%
Trade debts 44 €469 €612 +€143 +30.4%
Suppliers 440/4 €469 €612 +€143 +30.4%
Taxes, remuneration and social security 45 €6,057 €5,638 -€419 -6.9%
Taxes 450/3 €6,057 €5,638 -€419 -6.9%
Other amounts payable 47/48 €823 €808 -€14 -1.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €595 - -€595
Other operating charges 640/8 €204 €204 +€1 +0.3%
Gross operating margin 9900 €10,900 €6,748 -€4,152 -38.1%
Operating profit (loss) 9901 €10,102 €6,544 -€3,558 -35.2%
Financial charges 65/66B €1,658 €1,405 -€253 -15.3%
Recurring financial charges 65 €1,658 €1,405 -€253 -15.3%
Profit (loss) for the period before taxes 9903 €8,443 €5,138 -€3,305 -39.1%
Income taxes 67/77 €2,119 €1,690 -€429 -20.2%
Profit (loss) for the period 9904 €6,324 €3,449 -€2,876 -45.5%
Profit (loss) for the period to be appropriated 9905 €6,324 €3,449 -€2,876 -45.5%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.